You just read:

Janssen Submits Application to U.S. FDA Seeking Approval of STELARA®(ustekinumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Oct 07, 2019, 07:30 ET